NI: Analysis & Opinions

  1. DaVita and Myriad Join Forces - Analyst Blog

    June 18, 2013
    DaVita HealthCare entered into a strategic liaison with Myriad Genetics.
  2. Myriad: End to Legal Battle over Patents - Analyst Blog

    June 17, 2013
    Supreme Court reveals decision on Myriad's patent claims.
  3. Good News for Celgene's Revlimid - Analyst Blog

    June 17, 2013
    The EC approved Revlimid for MDS.
  4. Ball Completes Senior Secured Credit Facility - Analyst Blog

    June 14, 2013
    Ball Corp. has completed its senior secured credit facility.
  5. The Bullish Trend For Muni Bonds

    June 14, 2013
    For investors looking for tax-free income, the municipal bond sector continues to get stronger. It seems that states ...
  6. Nautilus CFO Steps Down - Analyst Blog

    June 14, 2013
    Linda Pearce, chief financial officer of Nautilus recently put down her papers.
  7. Amgen's Oncology Drug Meets Primary Endpoint - Analyst Blog

    June 13, 2013
    Median progression free survival was better in the trebananib arm compared to the control arm.
  8. Dynavax Down on Heplisav Delay - Analyst Blog

    June 11, 2013
    Dynavax recently suffered a setback when the US Food and Drug Administration (FDA) asked for additional safety data ...
  9. SGEN Starts Adcetris Phase I/II Study - Analyst Blog

    June 11, 2013
    Seattle Genetics commenced a phase I/II study to evaluate Adcetris in combination with Teva Pharma's Treanda ...
  10. Xenon Licenses Isis Drug - Analyst Blog

    June 11, 2013
    With Xenon exercising its option, Isis Pharma is entitled to receive $2 million from Xenon.
  11. Increasing Regulatory Burdens Depressing America Movil's ...

    June 10, 2013
    Increasing competition is going to cost America Movil margins and growth
  12. Encouraging Data on Alexion's Soliris - Analyst Blog

    June 10, 2013
    Alexion announced that encouraging data on Soliris has been published for treating aHUS patients.
  13. Priority Review for Gilead Drug - Analyst Blog

    June 10, 2013
    The NDA on Gilead's sofosbuvir will be reviewed on a priority basis by the FDA.
  14. Tiffany Earnings Preview: Revenue Growth, EPS Decline ...

    May 25, 2013
    Luxury spending bellwether Tiffany & Co. (NYSE: TIF), which recently announced its 12th dividend increase in the ...
  15. Mobile Mini Earnings Double: Is It Time To Buy?

    May 07, 2013
    Mobile Mini reported first quarter earnings May 6 that were impressive to say the least. With its stock sitting near ...
  16. Natural Gas: A Big Win For Israel And Its Producers

    April 02, 2013
    While it’s a tech powerhouse, the natural gas game is quickly changing Israel’s economy for the good. The recent ...
  17. CNI Puts Off Project Study - Analyst Blog

    February 13, 2013
    Uncertainty surrounding the mining sector compelled Canadian National Railway Company (CNI) to shelve the ...
  18. NIHD Provides Grim 2013 Outlook - Analyst Blog

    February 07, 2013
    Latin American wireless operator NII Holdings Inc. (NIHD) provided a dismal outlook for fiscal 2013, slashing its ...
  19. Scripps Networks Misses in 4Q - Analyst Blog

    February 07, 2013
    Scripps Networks Interactive Inc. (SNI) has reported weak financial results for the fourth quarter of 2012, which ...
  20. CNI: 2013 Capital Outlay - Analyst Blog

    February 06, 2013
    Canadian National Railway (CNI), leading Canadian Freight railroad announced capital investment of C$1.9 billion in ...
Marketplace
Trading Center